No abstract available
MeSH terms
-
Anticholesteremic Agents / adverse effects
-
Anticholesteremic Agents / therapeutic use*
-
Creatine Kinase / blood
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Liver / drug effects
-
Liver / enzymology
-
Lovastatin / adverse effects
-
Lovastatin / therapeutic use*
-
Meta-Analysis as Topic
-
Muscular Diseases / chemically induced
-
Pravastatin / adverse effects
-
Pravastatin / therapeutic use*
-
Pyridines / adverse effects
-
Pyridines / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Retrospective Studies
-
Rhabdomyolysis / chemically induced
-
Transaminases / blood
-
Treatment Outcome
Substances
-
Anticholesteremic Agents
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Pyridines
-
Lovastatin
-
cerivastatin
-
Transaminases
-
Creatine Kinase
-
Pravastatin